Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Findings in bioengineering reported from A. Ambade and co-researchers
February 17th, 2009
"The potential of cytokine gene therapy using naked plasmid DNA encoding human IL-2 cDNA in a xenograft nude mouse model was investigated. To overcome the T cell deficiency in nude mice, Adoptive T Cell Transfer [ATCT] into tumour bearing nude mice was performed," scientists in India report. "The migration of T cells was tracked in vivo using USE labeling. IL-2 in circulation was observed till day 15 with the levels reaching a peak by day 3. Significant activation of transferred T cells (CD69(+), CD25(+)) as well as significant increase in levels of NK cells (CD49b(+)) was seen in animals receiving IL-2," wrote A. Ambade and colleagues. The...
Source: Cancer Weekly (2009-02-17)
|
